New cancer clinical trial: Randomized Feasibility Trial in Men With Hormone Sensitive Oligometastatic Prostate Cancer
Published on: October 04, 2017 at 10:00AM
Condition: Hormone Sensitive Oligometastatic Prostate Cancer
Interventions: Procedure: Radical prostatectomy; Radiation: HDR (19Gy) or SBRT (35-40Gy)
Sponsor: Dr. Patrick Cheung
Recruiting
http://ift.tt/2gbUIjQ
More Stories
‘My 401k Misses You’: Black Woman Pumped To Meet Donald Trump In Philadelphia – July 18, 2023 at 04:56PM
Energy Provider Warns of Impending ‘Crisis,’ ‘Blackout Conditions’ Driven By Biden Plans – July 18, 2023 at 04:20PM
Dog starts barking at cows crossing a bridge, so the cows stop to have a look. – July 17, 2023 at 02:27PM